TEVA NI LIMITED
Get an alert when TEVA NI LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-21 (this month)
Last made up 2025-05-07
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£109M
+5.9% vs 2023
Employees
96
+3.2% vs 2023
Profit before tax
£8M
+16.2% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £11,384,000 | £12,473,000 | |
| Operating profit | £2,123,000 | £2,160,000 | |
| Profit before tax | £6,925,000 | £8,049,000 | |
| Net profit | £5,168,000 | £5,977,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £103,807,000 | £109,810,000 | |
| Net assets | £102,454,000 | £108,534,000 | |
| Equity | £102,454,000 | £108,534,000 | |
| Average employees | 93 | 96 | |
| Wages | £4,506,000 | £4,947,000 | |
| Directors' remuneration | £350,000 | £400,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+9.6%
£11,384,000 £12,473,000
-
Cash
—
Not reported
-
Net assets
+5.9%
£102,454,000 £108,534,000
-
Employees
+3.2%
93 96
-
Operating profit
+1.7%
£2,123,000 £2,160,000
-
Profit before tax
+16.2%
£6,925,000 £8,049,000
-
Wages
+9.8%
£4,506,000 £4,947,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 18.6% | 17.3% | |
| Net margin | 45.4% | 47.9% | |
| Return on capital employed | 2.0% | 2.0% | |
| Current ratio | 22.66x | 23.94x | |
| Interest cover | 64.33x | 34.29x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- TEVA NI LIMITED 2018-05-14 → present
- WARNER CHILCOTT UK LIMITED 2004-06-16 → 2018-05-14
- ROUVEX LIMITED 1989-11-14 → 2004-06-16
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of Teva Pharmaceuticals Europe B.V., a fellow group company. The directors have received confirmation from Teva Pharmaceuticals Europe B.V. that it has pledged its continuing support for a minimum on 12 months from the date of signing these financial statements.”
Significant events
- “The company's previous subsidiary holding, Teva Pharma UK Limited, was dissolved on 2 December 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COOPER, Dean Michael | Director | 2021-07-01 | Sep 1972 | British |
| GARVIN, David Harold James | Director | 2021-07-01 | Feb 1964 | British |
| MULDOON, Brendan Christopher Oliver | Director | 2016-04-08 | Sep 1976 | Irish |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ELLIOTT, Geoffrey | Secretary | 1989-11-14 | 2005-01-05 |
| WHITFORD, Robert | Secretary | 2005-02-02 | 2016-04-08 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| BOISSONNEAULT, Roger | Director | 2007-01-09 | 2011-09-30 |
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | 2021-07-01 |
| CHESTNUTT, Peter Vincent | Director | 2018-06-13 | 2021-07-01 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2020-04-29 |
| COULTER, Cathy | Director | 2011-01-20 | 2013-11-01 |
| ELLIOTT, Geoffrey | Director | 2001-09-30 | 2005-01-05 |
| GILLIGAN, Claire, Dr | Director | 2005-02-02 | 2016-04-08 |
| HEALEY, Peter David | Director | 2010-03-30 | 2010-10-21 |
| KING, John A | Director | 1989-11-14 | 2005-01-05 |
| MCCLAY, Allen James, Dr | Director | 1989-11-14 | 2001-10-04 |
| MCILROY, James William, Dr | Director | 2016-04-08 | 2018-03-14 |
| WHITFORD, Robert | Director | 2005-01-05 | 2016-04-08 |
| WILLIAMS, Robert | Director | 2016-08-02 | 2018-06-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Milbrook Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 165 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-05-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-03 | AA | accounts | Accounts with accounts type full | |
| 2024-05-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-02 | AA | accounts | Accounts with accounts type full | |
| 2023-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-09 | AA | accounts | Accounts with accounts type full | |
| 2022-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-04 | AA | accounts | Accounts with accounts type full | |
| 2021-07-07 | AP01 | officers | Appoint person director company with name date | |
| 2021-07-07 | AP01 | officers | Appoint person director company with name date | |
| 2021-07-07 | TM01 | officers | Termination director company with name termination date | |
| 2021-07-07 | TM01 | officers | Termination director company with name termination date | |
| 2021-05-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-03-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2020-11-10 | AA | accounts | Accounts with accounts type full | |
| 2020-05-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-04-29 | TM01 | officers | Termination director company with name termination date | |
| 2020-04-29 | AP01 | officers | Appoint person director company with name date | |
| 2019-10-03 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.